NASDAQ Index Blog - Posts with tag of "monthly performance"

May 2015 Monthly Index Performance Report By: Dave Gedeon
on 6/1/2015



Market performance in the month of May was driven by concerns about the economy’s health and the uncertainty of when the Fed will start to raise interest rates. In the background, news about the debt crisis in Greece also led media headlines.

The Nasdaq Biotechnology Index was May’s top performer with a 9.2% gain. The Nasdaq OMX Solar Index was the laggard for the month, shedding 8.4%. With its impressive gains, biotechnology continues to be a market leader in 2015. Despite a weak start to the month, the NASDAQ Composite rallied strongly to end the month higher by 2.6%, outperforming the 1.05% gain from the S&P 500. The Nasdaq Composite also crossed back above the key 5,000 level. Other notable strong performers include the Nasdaq PHLX Semiconductor Index (+8.6%), the Nasdaq Q-50 (+5.2%) and the Nasdaq OMX Wind Index (+7.5%).

The Nasdaq Biotechnology Index is May's top performer at 9.2% and the Nasdaq Solar Index is the worst performer of May at -8.4%. Get a quick overview of Nasdaq Index performance data for our top 50 most watched indexes here.

March 2015 Monthly Index Performance Report By: Dave Gedeon
on 4/2/2015



The OMX Index Family, the benchmarks of the Nordic markets, have experienced a strong start to 2015 on the back of a collapsing Krona. The SEK has weakened by over 10% year to date as the European continent, not just the Euro, have been on the wrong side of the US Dollar. Though that currency swing has richly rewarded investors in the local European equity markets with strong outperformance over the US market.

The Nasdaq Composite had a historic month in March as it crossed the 5000 threshold for the second time ever and first time since March 2000. The difference between 5,000 in March 2000 versus 5,000 in March 2015 has been widely dissected by the financial press but it bears pointing out again the massive shift the stocks listed on Nasdaq have undertaken in their fundamental strength while also driving significant innovation to the world through technology, health care and consumer goods.

The Nasdaq Q-50, the index comprised of the 50 companies that are next eligible to be members of the Nasdaq-100, has had strong returns of late. Q-50 has had one of the strongest Q1s which was largely driven by its high exposures to biotech which drove over 45% of the gain of the quarter. Biotech’s impressive gains continued into 2015 fueled by mid-cap names such as Biomarin Pharma and United Therapeutics.

The Nasdaq Solar Index is March's top performer at 9.5% and the PHLX Gold/Silver Sector Index is the worst performer of March at -14.9%. Get a quick overview of Nasdaq Index performance data for our top 50 most watched indexes here.

February 2015 Monthly Performance Report By: Dave Gedeon
on 3/10/2015


The Nasdaq Composite ended February poised to break through 5000 as an incredibly strong February fueled growth in U.S. stocks as earnings came in strong and growth prospects for macro environment brightened. Interestingly, energy experienced a bounce up in February though whether those gains are sustainable or just the dead cat bouncing remains to be seen.

The Nasdaq Solar Index is February's top performer at 17.6% and the Nasdaq Commodity Gold ER Index is the worst performer of February at -5.2%. Get a quick overview of Nasdaq Index performance data for our top 50 most watched indexes here.

January 2015 Monthly Performance Report Updated: 2/4/2015

The Nasdaq PHLX Gold/Silver Sector Index is January's top performer at 15.4% and the Nasdaq Commodity HG Copper ER Index is the worst performer of January at -11.7%. Get a quick overview of Nasdaq Index performance data for our top 50 most watched indexes here.

December 2014 Monthly Performance Report Updated: 1/9/2015

The Nasdaq Axioma Equity-Commodity Gold Index is December's top performer at 5.6% and the Nasdaq Commodity Natural Gas ER Index is the worst performer of December at -29.5%. Get a quick overview of Nasdaq Index performance data for our top 50 most watched indexes here.

October Monthly Performance Report Updated: 11/4/2014

The NASDAQ Biotechnology Index is October's top performer at 8.5% and the PHLX Gold/Silver Sector Index is the worst performer of October at -20.0%. Get a quick overview of Nasdaq Index performance data for our top 50 most watched indexes here.

June Monthly Performance Report Updated: 7/10/2014

The PHLX Gold/Silver Sector Index is June's top performer at 18.5% and the OMX Stockholm 30 Index is the worst performer of June at -1.8%. Get a quick overview of NASDAQ OMX Index performance data for our top 50 most watched indexes here.

May Monthly Performance Report Updated: 6/3/2014

The NASDAQ OMX Wind Index is May's top performer at 14% and the PHLX Gold/Silver Sector Index is the worst performer of May at -7.8%. Get a quick overview of NASDAQ OMX Index performance data for our top 50 most watched indexes here.

April Monthly Performance Report Updated: 5/1/2014

The NASDAQ OMX Commodity Natural Gas ER Index is April's top performer at 9.4% and the NASDAQ OMX Solar Index is the worst performer of April at -8.1%. Get a quick overview of the NASDAQ OMX Index performance data for our top 50 most watched indexes here.

March Monthly Performance Report Updated: 4/3/2014

The NASDAQ OMX Axioma Equity-Commodity Oil Index is March's top performer at 4.6% and the NASDAQ Biotechnology Index is the worst performer of March at -10.7%. Get a quick overview of NASDAQ OMX Index performance data for our top 50 most watched indexes here.

December Monthly Performance Report Updated: 1/3/2014

The NASDAQ Commodity Natural Gas ER Index is December's top performer at 7.1% and the NASDAQ Axioma Equity-Commodity Gold Index is the worst performer of December at -4.7%. Get a quick overview of NASDAQ OMX Index performance data for our top 50 most-watched indexes here.

NASDAQ® and NASDAQ® are registered trademarks of The NASDAQ Group, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither The NASDAQ Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding NASDAQ-listed companies or NASDAQ proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

© 2015. The NASDAQ Group, Inc. All Rights Reserved.

Loading...
Account Sign In